Graybill Bartz & Assoc LTD Abbott Laboratories Transaction History

Graybill Bartz & Assoc LTD

  • $249 Million
  • Q3 2024

A detailed history of Graybill Bartz & Assoc LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Graybill Bartz & Assoc LTD holds 49,659 shares of ABT stock, worth $5.85 Million. This represents 2.27% of its overall portfolio holdings.

Number of Shares
49,659
Previous 48,288 2.84%
Holding current value
$5.85 Million
Previous $5.02 Million 12.84%
% of portfolio
2.27%
Previous 2.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
BUY
$100.07 - $118.13 $137,195 - $161,956
1,371 Added 2.84%
49,659 $5.66 Million
Q2 2024

Jul 22, 2024
BUY
$100.73 - $112.44 $178,493 - $199,243
1,772 Added 3.81%
48,288 $5.02 Million
Q1 2024

Apr 15, 2024
BUY
$109.52 - $120.96 $52,241 - $57,697
477 Added 1.04%
46,516 $5.29 Million
Q4 2023

Feb 08, 2024
BUY
$90.19 - $110.4 $19,030 - $23,294
211 Added 0.46%
46,039 $5.07 Million
Q3 2023

Nov 03, 2023
SELL
$95.53 - $114.62 $2,483 - $2,980
-26 Reduced 0.06%
45,828 $4.44 Million
Q2 2023

Jul 21, 2023
BUY
$100.78 - $112.29 $19,148 - $21,335
190 Added 0.42%
45,854 $5 Million
Q1 2023

Apr 27, 2023
BUY
$96.86 - $114.01 $111,970 - $131,795
1,156 Added 2.6%
45,664 $4.62 Million
Q4 2022

Jan 23, 2023
BUY
$95.06 - $111.52 $55,324 - $64,904
582 Added 1.32%
44,508 $0
Q3 2022

Oct 28, 2022
BUY
$96.76 - $112.03 $68,893 - $79,765
712 Added 1.65%
43,926 $4.25 Million
Q2 2022

Jul 29, 2022
SELL
$102.07 - $123.37 $126,362 - $152,732
-1,238 Reduced 2.79%
43,214 $4.7 Million
Q1 2022

May 12, 2022
SELL
$114.02 - $139.04 $896,539 - $1.09 Million
-7,863 Reduced 15.03%
44,452 $5.26 Million
Q4 2021

Jan 28, 2022
BUY
$115.53 - $141.46 $56,032 - $68,608
485 Added 0.94%
52,315 $7.36 Million
Q3 2021

Oct 22, 2021
SELL
$116.66 - $129.06 $62,763 - $69,434
-538 Reduced 1.03%
51,830 $6.12 Million
Q2 2021

Jul 27, 2021
BUY
$105.79 - $124.53 $132,025 - $155,413
1,248 Added 2.44%
52,368 $6.07 Million
Q1 2021

Apr 19, 2021
SELL
$108.84 - $128.23 $174,905 - $206,065
-1,607 Reduced 3.05%
51,120 $6.13 Million
Q4 2020

Jan 20, 2021
SELL
$105.0 - $114.42 $29,820 - $32,495
-284 Reduced 0.54%
52,727 $5.77 Million
Q3 2020

Oct 19, 2020
SELL
$91.64 - $111.29 $13,012 - $15,803
-142 Reduced 0.27%
53,011 $5.77 Million
Q2 2020

Jul 20, 2020
SELL
$76.57 - $98.0 $62,021 - $79,380
-810 Reduced 1.5%
53,153 $4.86 Million
Q1 2020

Apr 30, 2020
SELL
$62.82 - $91.86 $42,215 - $61,729
-672 Reduced 1.23%
53,963 $4.26 Million
Q4 2019

Jan 24, 2020
SELL
$78.51 - $87.4 $38,155 - $42,476
-486 Reduced 0.88%
54,635 $4.75 Million
Q3 2019

Oct 24, 2019
SELL
$81.84 - $88.74 $106,801 - $115,805
-1,305 Reduced 2.31%
55,121 $4.61 Million
Q2 2019

Jul 25, 2019
BUY
$72.88 - $85.0 $3,425 - $3,995
47 Added 0.08%
56,426 $4.75 Million
Q1 2019

Apr 24, 2019
SELL
$66.22 - $80.06 $49,002 - $59,244
-740 Reduced 1.3%
56,379 $4.51 Million
Q4 2018

Feb 06, 2019
BUY
$65.56 - $74.27 $152,099 - $172,306
2,320 Added 4.23%
57,119 $4.13 Million
Q3 2018

Oct 12, 2018
SELL
$60.81 - $73.36 $16,418 - $19,807
-270 Reduced 0.49%
54,799 $4.02 Million
Q2 2018

Jul 23, 2018
SELL
$57.57 - $63.54 $110,822 - $122,314
-1,925 Reduced 3.38%
55,069 $3.36 Million
Q1 2018

Apr 18, 2018
SELL
$56.27 - $63.62 $388,713 - $439,486
-6,908 Reduced 10.81%
56,994 $3.42 Million
Q4 2017

Jan 16, 2018
SELL
$53.68 - $57.47 $565,840 - $605,791
-10,541 Reduced 14.16%
63,902 $3.65 Million
Q3 2017

Oct 18, 2017
BUY
$48.06 - $53.64 $3.58 Million - $3.99 Million
74,443
74,443 $3.97 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Graybill Bartz & Assoc LTD Portfolio

Follow Graybill Bartz & Assoc LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graybill Bartz & Assoc LTD, based on Form 13F filings with the SEC.

News

Stay updated on Graybill Bartz & Assoc LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email